Myosin 1e deficiency affects migration of 4T1 breast cancer cells.
Michael E GaroneSharon E ChaseChunling ZhangMira KrendelPublished in: Cytoskeleton (Hoboken, N.J.) (2023)
Metastasis of breast cancer cells to distant tissue sites is responsible for the majority of deaths associated with breast cancer. Previously we have examined the role of class I myosin motor protein, myosin 1e (myo1e), in cancer metastasis using the Mouse Mammary Tumor Virus-Polyoma Middle T Antigen (MMTV-PyMT) mouse model. Mice deficient in myo1e formed tumors with a more differentiated phenotype relative to the wild-type mice and formed no detectable lung metastases. In the current study, we investigated how the absence of myo1e affects cell migration and invasion in vitro, using the highly invasive and migratory breast cancer cell line, 4T1. 4T1 cells deficient in myo1e exhibited an altered morphology and slower rates of migration in the wound-healing and transwell migration assays compared to the WT 4T1 cells. While integrin trafficking and Golgi reorientation did not appear to be altered upon myo1e loss, we observed lower rates of focal adhesion disassembly in myo1e-deficient cells, which could help explain the cell migration defect.
Keyphrases
- wild type
- cell migration
- breast cancer cells
- binding protein
- mouse model
- induced apoptosis
- wound healing
- high fat diet induced
- squamous cell carcinoma
- papillary thyroid
- type diabetes
- escherichia coli
- lymph node
- stem cells
- cell cycle arrest
- young adults
- cell death
- staphylococcus aureus
- cell proliferation
- cell therapy
- childhood cancer
- small molecule
- oxidative stress
- signaling pathway
- endoplasmic reticulum stress
- lymph node metastasis
- candida albicans
- soft tissue
- pi k akt